drugset / Trial / NCT00654225

Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)

NCT00654225

Phase 3 Completed 2340 enrolled AstraZeneca
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effect of 6 weeks of treatment with Rosuvastatin with 6 weeks of treatment with Atorvastatin in South Asian subjects with hypercholesterolemia.

Timeline

Start
2002-10
Primary completion
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule
Subject Rosuvastatin Small molecule

Indications